CSNK2B and nonpapillary renal cell carcinoma: However, this does not hold for the ccRCC samples corresponding to more advanced tumors (G3/G4 and pT3), which showed decreases in total CK2β levels when analyzed by western blot or more specifically in cytosolic CK2β when analyzed by immunohistochemistry.